(Date:7/18/2008)...ersity of Pennsylvania School of Medicine have sho...familial Alzheimer,s disease disrupt the flow of c...ed PS1 and PS2 (presenilin 1 and 2), interact with...l compartment. , "The ,calcium dysregulation, hy...imer,s disease has been suggested by previous rese...
(Date:7/18/2008)...tion to develop an integrated, comprehensive, nati...of losing its status as the global health care lea...on of Academic Health Centers (AAHC, www.aahcdc.o... Macy, Jr. Foundation. , Out of Order, Out of Ti...ns that the nation is running out of time to ensur...
(Date:7/18/2008)...to chemotherapy drugs, sometimes abruptly, after a... to reduce tumors or hold them in check? Although...this occurs is all too familiar: patients relapse ...sistant. , A team of researchers at Cold Spring ...e genetic underpinnings of cancer therapy response...
(Date:7/18/2008)...- Baxa Corporation, a,Denver-based manufacturer of...ng, packaging, and administering medications, anno... health-system users of its software and,pharmacy ...UG for,electronic Baxa Users, Group, offers a vari...irtual ,community, for sharing pharmacy best pract...
Breaking Medicine News(10 mins):Health News:Calcium may be the key to understanding Alzheimer's disease 2Health News:Calcium may be the key to understanding Alzheimer's disease 3Health News:New report warns current policies will not avert health workforce crisis 2Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 2Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 3Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 4Health News:Baxa Corporation Launches New Electronic Users' Group Web Site 2...n people worldwide suffer from Filarial infection ...iasis, where their legs resemble that of an Elepha...uchereria bancrofti, this is a threadlike worm The...es where they cause the blockage of the flow of ly...
...immunity that had lead to inability to curbing of ...may have genes that act likewise. Researchers from...that the FOXP3 gene may be responsible for the low...s of multiple sclerosis. Multiple sclerosis is a c...
...ty disorder is common in people who are into subst...t was conducted by National Institute on Drug Abus...,000 adults of USA. Antisocial personality disorde...hat is characterized by behavior that tends to man...
...thyroid cancer may be detectable using a blood tes...according to a study published by researchers at ...ter and Arthur G. James Cancer Hospital and Richa...re published June 21 online in the Journal of Clin...
Other Medicine News:Health News:Antibiotics help combat dangerous tropical disease 2Health News:Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available 2(Date:7/16/2008)...lif., July 16 /- MAP,Pharma...e positive results,from a Phase 2 study evaluating...MAP0004 in adult asthmatics were published in the .... MAP Pharmaceuticals is,developing MAP0004, an or...otential treatment for migraine., The study resul...
(Date:7/15/2008)... 15 /- Abeome Corporation, a,Georgia-... equity,investment by Cato BioVentures and a colla...act research and development organization. The inv...ued development of Abeome,s lead,ovarian cancer pr...proves the development of,monoclonal antibodies an...
(Date:7/15/2008)...pletion of Phase III Trials of Light Infusion Ther...orectal Cancer and Phase I/II and Phase ...E, Wash., July 15 /- Light Sciences O...loping Light Infusion Therapy(TM),(Litx(TM)) to tr...hat it,has raised $40.1 million in a Series C roun...
(Date:7/15/2008)...lysis of the Alzheimer,s Disease Market Now Availa..., WALTHAM, Mass., July 15 /- Decisio...nd advisory firms for pharmaceutical and,healthcar...,s decision to,discontinue the development of Flur...fying Alzheimer,s disease treatment becomes Elan/W...
Breaking Medicine Technology:MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2Light Sciences Oncology Raises $40.1 Million in Series C Financing 2Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimer's Drug After Flurizan's Discontinuation 2AMDLs First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou China 2287 1AMDLs First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou China 2287 2Avastin Approved in Europe for First Line Treatment of Patients With Advanced Kidney Cancer 2285 1Avastin Approved in Europe for First Line Treatment of Patients With Advanced Kidney Cancer 2285 2Avastin Approved in Europe for First Line Treatment of Patients With Advanced Kidney Cancer 2285 3UT Southwestern secures 245 million NIH grant for lupus research 1665 1UT Southwestern secures 245 million NIH grant for lupus research 1665 2Council for Responsible Nutrition Calls Proposed DHEA Legislation A Solution in Search of a Problem 8513 1Council for Responsible Nutrition Calls Proposed DHEA Legislation A Solution in Search of a Problem 8513 2...OSTON, May 03, 2007 /PRNewswire/ -- Bayer HealthCa...three clinical,studies with Betaseron(R) (interfer...cademy of Neurology,s (AAN) 59th Annual Meeting,d...y, and high,patient satisfaction with treatment in...is (MS). , "Collectively, these studies highlight ...
...ISSISSAUGA, ON, May 02, 2007 /PRNewswire-FirstCall... identifies, develops,and commercializes different...nced top-line results from its randomized,placebo...id naive,patients with post-operative pain followi... endpoint of the study, showing a,statistically si...
Other Medicine Technology:Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets,Primary Endpoint in Patients with Post-Surgical Pain 2YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets,Primary Endpoint in Patients with Post-Surgical Pain 3The A350 test is used for POC testing in hospital emergency departments, replacing the need to draw blood for alcohol testing. Each hash mark is 0.02% or 20 mg/dL.
...en multi-panel dip cards offer minimal exposure to...ble combination of 9 different drugs. QuickScreen ... testing program. Just dip the card into the speci...the results. Our special slit-lid cup prevents spl...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP).
...re available in 14 configurations including the ne...ogenics Antibody Technology, the SureStep™ M...oassay targeted to detect MDMA that has an affinit... any isomer of methamphetamine or amphetamine.The ...
Medicine Products: